MAM
SLS icon

Meeder Asset Management’s SELLAS Life Sciences SLS Stock Holding History

Meeder Asset Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-51
Closed -$3K – 1838
2018
Q4 		$3K Sell
51
-84
-62% -$6.5K ﹤0.01% 1525
2018
Q3 		$8K Buy
135
+108
+400% +$7.45K ﹤0.01% 1216
2018
Q2 		$4.63K Buy
27
+5
+23% +$1.37K ﹤0.01% 1294
2018
Q1 		$4K Buy
22
+11
+100% +$3.14K ﹤0.01% 1287
2017
Q4 		$4K Buy
11
+1
+10% +$484 ﹤0.01% 1382
2017
Q3 		$5K Buy
10
+9
+900% +$5.94K ﹤0.01% 1278
2017
Q2 		$1K Hold
1
– – ﹤0.01% 1550
2017
Q1 		$1K Hold
1
– – ﹤0.01% 1550
2016
Q4 		$3K Buy
+1
New +$5.82K ﹤0.01% 906

Other funds holding SLS

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Meeder Asset Management's SLS Position: Q1 2019 in Review

Meeder Asset Management sold out of SELLAS Life Sciences (SLS) in Q1 2019, closing a stake of 51 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in SLS in Q4 2016 and held it in 9 quarters. The position peaked at $8K in Q3 2018. 11 funds tracked by Wall St. Rank hold SLS as of Q1 2019.

  • Meeder Asset Management reported no remaining SELLAS Life Sciences position as of Q1 2019 after selling out during the quarter.
  • Meeder Asset Management sold 51 SELLAS Life Sciences shares in Q1 2019, an estimated $3K.
  • Meeder Asset Management first reported a position in SELLAS Life Sciences in Q4 2016 and held it in 9 quarters.
  • Meeder Asset Management's SELLAS Life Sciences position peaked at $8K in Q3 2018.
  • 11 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2019.

Based on Meeder Asset Management's 13F filing for Q1 2019, filed 16 Apr 2019.